RXI PHARMACEUTICALS


Updates from The Motley Fool

Latest updates on RXi Pharmaceuticals from Fool.com.

There is no available coverage of RXi Pharmaceuticals at this time.



Stock Performance

RXII vs. S&P 500 | 2 Year Performance
View Interactive RXII Charts
Sponsored by

Key Data Points

Primary metrics and data points about RXi Pharmaceuticals.
Current Price: $1.85
Prev Close: $1.89
Open: $1.94
Bid: $1.66
Ask: $1.94
Day's Range: $1.84 - $1.94
52wk Range: $1.26 - $6.49
Volume: 12,448
Avg Vol 26,139
Market Cap: $121M
P/E (ttm): -0.27
EPS (ttm): ($7.02)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about RXi Pharmaceuticals.
CAPS Rating 2 out of 5
 
188 Outperform
20 Underperform
CAPS All Stars
 
21 Outperform
8 Underperform

How do you think RXi Pharmaceuticals will perform against the market?



You pick for RXi Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Noah D. Beerman, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for RXi Pharmaceuticals.

RXI PHARMACEUTICALS

  • Exchange: NASDAQ